# Haemocomplettan® P During Aortic Replacement

> **NCT00701142** · PHASE2 · COMPLETED · sponsor: **CSL Behring** · enrollment: 80 (actual)

## Conditions studied

- Aortic Aneurysm

## Interventions

- **BIOLOGICAL:** Haemocomplettan® P
- **BIOLOGICAL:** Saline solution

## Key facts

- **NCT ID:** NCT00701142
- **Lead sponsor:** CSL Behring
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2010-03
- **Final completion:** 2010-04
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2013-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00701142

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00701142, "Haemocomplettan® P During Aortic Replacement". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00701142. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*